| Literature DB >> 30018026 |
Gerald Thiel1, Myriam Ulrich2, Naofumi Mukaida3, Oliver G Rössler2.
Abstract
The polyphenol resveratrol activates stimulus-regulated transcription factors, including activator protein-1 (AP-1). As part of a search for resveratrol-regulated target genes we analyzed the gene encoding the chemokine interleukin-8 (IL-8) which is regulated by AP-1. Here, we show that treatment of HEK293 cells with resveratrol induced the expression of IL-8 and activated transcription of a chromatin-embedded IL-8 promoter-controlled reporter gene. Mutational analysis of the IL-8 promoter revealed that it was not the AP-1 binding site, but rather the NF-κB site that was essential to connect resveratrol stimulation with the transcriptional activation of the IL-8 gene. Thus, the NF-κB site of the IL-8 gene functions as resveratrol-responsive element. The analysis of an NF-κB-responsive reporter gene, controlled by the HIV-1 long terminal repeat (LTR), showed that resveratrol stimulation increased the transcriptional activity of NF-κB. These data were corroborated by an experiment showing that incubation of the cells with the NF-κB inhibitor JSH-23 attenuated resveratrol-induced activation of the IL-8 promoter and reduced the cellular NF-κB activity following stimulation of the cells with resveratrol. The protein kinase extracellular signal-regulated protein kinase ERK1/2 was identified to function as signal transducer connecting resveratrol stimulation with the activation of NF-κB and IL-8 promoter-controlled transcription. We conclude that resveratrol, proposed to exhibit anti-inflammatory activity, stimulates expression of the pro-inflammatory chemokine IL-8 via NF-κB, which is known as an important mediator of inflammatory processes.Entities:
Keywords: 12-O-tetradecanoylphorbol-13-acetate (TPA), PubChem CID: 27924; ERK1/2; JSH-23, PubChem CID: 16760588; NF-κB; Resveratrol PubChem CID: 445154; TLR4; interleukin-1β; interleukin-8
Mesh:
Substances:
Year: 2018 PMID: 30018026 DOI: 10.1016/j.phrs.2018.07.003
Source DB: PubMed Journal: Pharmacol Res ISSN: 1043-6618 Impact factor: 7.658